Response to Dual Antiplatelet Therapy Does Not Impact Bleeding Risks in Patients Undergoing Oral Surgery after Acute Coronary Syndromes

Publisher： Karger

E-ISSN： 1421-9751|132|2|119-123

ISSN： 0008-6312

Source： Cardiology, Vol.132, Iss.2, 2015-07, pp. : 119-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre‐treatment with dual antiplatelet therapy in patients with non‐ST‐segment elevation acute coronary syndromes undergoing percutaneous coronary intervention

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1032-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?

By  

Cardiology, Vol. 126, Iss. 4, 2013-10 ,pp. : 233-243

Karger

Access to resources Recommend Favorite

Meta-Analysis of Trials Comparing Oral Anticoagulation and Aspirin versus Dual Antiplatelet Therapy after Coronary Stenting

By  

Cardiology, Vol. 104, Iss. 2, 2005-08 ,pp. : 101-106

Karger

Access to resources Recommend Favorite

Does Preoperative Platelet Function Predict Bleeding in Patients Undergoing Off Pump Coronary Artery Bypass Surgery?

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 3, 2015-06 ,pp. : 223-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management

By Cowley Michael J.   Kuritzky Louis  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1477-1490

Informa Healthcare

Access to resources Recommend Favorite